Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Genenta Science S.p.A. - American Depositary Shares (NQ:GNTA)

3.450 -2.750 (-44.35%)
Streaming Delayed Price Updated: 10:51 AM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genenta Science S.p.A. - American Depositary Shares

< Previous 1 2 3 Next >
Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results
 
Via Benzinga
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
From GENENTA SCIENCE SPA
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Myseum (NASDAQ: MYSE) CEO Darin Myman Highlights Privacy-Driven Future of Social Media – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October
 
Via Benzinga
Topics Stocks
Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings
 
Via Benzinga
Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production
Genenta Science shares jumped ~324% premarket to $13.69 after expanding its plasmid DNA collaboration with ANEMOCYTE. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE. 
Via Stocktwits
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
From GENENTA SCIENCE SPA
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
Genitourinary Tumor Study Ongoing with Active Screening and Enrollment 
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
Anemocyte established Cell Banks and Plasmids for Viral Vector Production 
From GENENTA SCIENCE SPA; Anemocyte
Via GlobeNewswire
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Sharing Insights at the 'Italy on the Move' Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in San Francisco 
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
From GENENTA SCIENCE SPA
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2 
From GENENTA SCIENCE SPA
Via GlobeNewswire
7 Penny Biotech Stocks to Triple Your Investment
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. 
Via InvestorPlace
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.